{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:46:50Z","timestamp":1773290810448,"version":"3.50.1"},"reference-count":37,"publisher":"The Journal of Rheumatology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>We examined the association between serum uric acid (SUA) level and the frequency, risk, and cost of gout flares among the elderly.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Data were extracted from the Integrated Healthcare Information Services claims database (1999\u20132005). Patients were included if they had gout, were aged 65 years and older and had both medical and pharmacy benefits, and electronic laboratory data. Patients with gout and gouty episodes were identified using algorithms based on ICD-9-CM codes and medications. Logistic regression and negative binomial regressions were used to study the relationship between SUA concentration and the annual frequency and one-year risk of gout episodes. Generalized linear models were used to examine the direct healthcare costs associated with gout episodes in the 30 days following each episode.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Elderly patients with gout (n = 2237) with high (6\u20138.99 mg\/dl) and very high (&gt; 9 mg\/dl) SUA concentrations were more likely to develop a flare within 12 months compared to patients with normal (&lt; 6 mg\/dl) SUA levels (OR 2.1, 95% CI 1.7\u20132.6; OR 3.4, 95% CI 2.6\u20134.4, respectively). In multivariate regressions, the average annual number of flares increased by 11.9% (p &lt; 0.001) with each unit-increase in SUA level above 6 mg\/dl (p &lt; 0.001). Among patients with very high SUA levels, average adjusted total healthcare and gout-related costs per episode were $2,555 and $356 higher, respectively, than those of patients with normal SUA levels (both p &lt; 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Higher SUA levels are associated with increased frequency and risk of gout episode, and with higher total and gout-related direct healthcare costs per episode.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.080487","type":"journal-article","created":{"date-parts":[[2009,4,16]],"date-time":"2009-04-16T01:05:56Z","timestamp":1239843956000},"page":"1032-1040","source":"Crossref","is-referenced-by-count":74,"title":["Frequency, Risk, and Cost of Gout-related Episodes Among the Elderly: Does Serum Uric Acid Level Matter?"],"prefix":"10.3899","volume":"36","author":[{"given":"ERIC Q.","family":"WU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PANKAJ A.","family":"PATEL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"REEMA R.","family":"MODY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANDREW P.","family":"YU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEVIN E.","family":"CAHILL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JACKSON","family":"TANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ESWAR","family":"KRISHNAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2009,4,15]]},"reference":[{"key":"2018112909192544000_36.5.1032.1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.33911"},{"key":"2018112909192544000_36.5.1032.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80158-3"},{"key":"2018112909192544000_36.5.1032.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03470210072035"},{"key":"2018112909192544000_36.5.1032.4","first-page":"1582","article-title":"Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population","volume":"31","author":"Wallace","year":"2004","journal-title":"J Rheumatol"},{"key":"2018112909192544000_36.5.1032.5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-7-200510040-00009"},{"key":"2018112909192544000_36.5.1032.6","first-page":"2403","article-title":"Epidemiology of gout: is the incidence rising?","volume":"29","author":"Arromdee","year":"2002","journal-title":"J Rheumatol"},{"key":"2018112909192544000_36.5.1032.7","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(94)00244-K"},{"key":"2018112909192544000_36.5.1032.8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.1.22"},{"key":"2018112909192544000_36.5.1032.9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.bor.0000209435.89720.7c","article-title":"New insights into gout epidemiology","volume":"18","author":"Mikuls","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"2018112909192544000_36.5.1032.10","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200205000-00015"},{"key":"2018112909192544000_36.5.1032.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602153340707"},{"key":"2018112909192544000_36.5.1032.12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.21.2857"},{"key":"2018112909192544000_36.5.1032.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp030733"},{"key":"2018112909192544000_36.5.1032.14","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90441-4"},{"key":"2018112909192544000_36.5.1032.15","first-page":"498","article-title":"Gout in ambulatory care settings in the United States","volume":"35","author":"Krishnan","year":"2008","journal-title":"J Rheumatol"},{"key":"2018112909192544000_36.5.1032.16","doi-asserted-by":"publisher","DOI":"10.1002\/art.20405"},{"key":"2018112909192544000_36.5.1032.17","doi-asserted-by":"publisher","DOI":"10.1097\/01.rhu.0000209882.50228.9f"},{"key":"2018112909192544000_36.5.1032.18","first-page":"459","article-title":"Clinical, humanistic, and economic outcomes of gout","volume":"11","author":"Brixner","year":"2005","journal-title":"Am J Managed Care"},{"key":"2018112909192544000_36.5.1032.19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.18553\/jmcp.2008.14.2.164","article-title":"Disease-related and all-cause health care costs of elderly patients with gout","volume":"14","author":"Wu","year":"2008","journal-title":"J Manag Care Pharm"},{"key":"2018112909192544000_36.5.1032.20","first-page":"908","article-title":"A cost effectiveness analysis of urate lowering drugs in nontophaceous recurrent gouty arthritis","volume":"22","author":"Ferraz","year":"1995","journal-title":"J Rheumatol"},{"key":"2018112909192544000_36.5.1032.21","first-page":"S83","article-title":"An assessment of the diagnosed prevalence of diseases in men 50 years of age or older","volume":"12","author":"Issa","year":"2006","journal-title":"Am J Managed Care"},{"key":"2018112909192544000_36.5.1032.22","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000204287.82701.9b"},{"key":"2018112909192544000_36.5.1032.23","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200624020-00006"},{"key":"2018112909192544000_36.5.1032.24","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.21.2497"},{"key":"2018112909192544000_36.5.1032.25","unstructured":"The International classification of diseases, 9th revision, clinical modification. 4th ed. Washington, DC: U.S. Department of Health and Human Services; 1991."},{"key":"2018112909192544000_36.5.1032.26","unstructured":"Healthcare common procedure coding system, medical national level II codes, 2007. Los Angeles: Practice Management Information Corp.; 2006."},{"key":"2018112909192544000_36.5.1032.27","unstructured":"Current procedure terminology 2007, standard edition. Washington, DC: American Medical Association; 2006."},{"key":"2018112909192544000_36.5.1032.28","first-page":"925","article-title":"Gout and hyperuricemia","volume":"59","author":"Harris","year":"1999","journal-title":"Am Fam Physician"},{"key":"2018112909192544000_36.5.1032.29","unstructured":"Hershfield MS . Gout and uric acid metabolism. In: Bennett JS Plum F , editors. Cecil textbook of medicine. 20th ed. Philadelphia: W.B. Saunders Company; 1996:1508\u201315."},{"key":"2018112909192544000_36.5.1032.30","unstructured":"Reginato AJ . Gout and other crystal arthropathies. In: Kasper DL Braunwald E Fauci AS , et al, editors. Harrison\u2019s principles of internal medicine. 16th ed. New York: McGraw-Hill; 2005."},{"key":"2018112909192544000_36.5.1032.31","unstructured":"IHCIS national managed care benchmark database user manual. Waltham, MA: Integrated Healthcare Information Services, Inc.; 2005."},{"key":"2018112909192544000_36.5.1032.32","first-page":"577","article-title":"Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?","volume":"28","author":"Li-Yu","year":"2001","journal-title":"J Rheumatol"},{"key":"2018112909192544000_36.5.1032.33","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.055269"},{"key":"2018112909192544000_36.5.1032.34","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90133-8"},{"key":"2018112909192544000_36.5.1032.35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.5694\/j.1326-5377.2000.tb124075.x","article-title":"Clinical manifestations of gout and their management","volume":"172","author":"Van Doornum","year":"2000","journal-title":"Med J Aust"},{"key":"2018112909192544000_36.5.1032.36","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000162060.25895.a5"},{"key":"2018112909192544000_36.5.1032.37","doi-asserted-by":"publisher","DOI":"10.1002\/art.22474"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.080487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T05:21:03Z","timestamp":1633324863000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.080487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,15]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,5,12]]},"published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.3899\/jrheum.080487"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.080487","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,15]]}}}